Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theraflu Aktiv for URTI Symptoms
NCT02678234Phase 3Withdrawn
- Sponsor
- GSK
- Start
- Feb 2017
- Primary completion
- Apr 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of acetaminophen, phenylephrine, ascorbic acid in upper respiratory tract infection (URI), common cold, influenza, sponsored by GSK. Planned start Feb 2017; status: withdrawn.
02
Drugs
acetaminophenphenylephrineascorbic acid
03
Conditions
upper respiratory tract infection (URI)common coldinfluenza
Beyond the preview
Go deeper on NCT02678234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02678234.